Skip to content
MomMetabolicEVIDENCE-FIRST METABOLIC HEALTH
Menu

Alternatives · care and cost compared

Alternatives to The Edit

People usually look past The Edit because it scores lowest on postpartum & breastfeeding guidance (32/100) in our rubric, and because compounded only — no FDA-approved Wegovy, Ozempic, Zepbound or Mounjaro.

Where The Edit is strongest
Clinical oversight & labs — 82/100
Semaglutide
$259/mo
Tirzepatide
$349/mo
Coverage
All 50 states

Compare the The Edit review with the options below. CoreAge Rx is a featured partner; commissions do not change a provider's score.

Featured partner

Metabolic-Fit 86/100 · Grade B

CoreAge Rx

CoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.

Semaglutide
$79/mo advertised flat price; confirm prescription quantity and total
Tirzepatide
$129/mo advertised flat price; confirm prescription quantity and total
Coverage
US service; state restrictions vary by therapy — confirm during intake
Brand-name
Compounded only

More alternatives for your priorities

ShedRx

Metabolic-Fit 76/100 · Grade C

The widest menu on our list — injections, sublingual lozenges, daily drops, four brand-name pens and the approved oral GLP-1 — with three compounding pharmacies named, prices published for every plan length, and cancellation terms among the most restrictive we have read.

  • $60 less per month on average than The Edit
  • offers FDA-approved brand pens, not just compounded
  • has an oral option if you would rather not inject

RxSpan MD

Metabolic-Fit 57/100 · Grade C

RxSpan MD is a genuinely well-disclosed service wrapped in marketing that undercuts it. The disclosure: four compounding pharmacies named with phone numbers, two lead physicians named with NPI numbers that verify as active MDs, flat pricing posted before any intake, both compounded and real FDA-approved brand GLP-1s on one platform, and oral capsules for anyone who won't inject. Compounded semaglutide is $249 a month and tirzepatide $329, with brand Zepbound at $1,069, Ozempic at $1,299 and Wegovy at $1,349. The marketing is the problem. Its testimonials still name a different company — one patient describes what she 'expected from CareGLP' — and the doctors quoted in them are not the clinicians the same page names as its medical team. The homepage is built around a board-certified plastic surgeon who founded the practice but is licensed in California only and isn't the prescriber. Its compounded prices also sit above the typical price we track, and the oral capsules cost the same or more than the injections.

  • $10 less per month on average than The Edit
  • offers FDA-approved brand pens, not just compounded
  • has an oral option if you would rather not inject

Wisp

Metabolic-Fit 56/100 · Grade C

A women's health brand many mothers already use for birth control or UTIs, now offering GLP-1 care. Its only compounded option is semaglutide drops held under the tongue, $225 for a 28-day bottle, so there is no needle and no compounded tirzepatide. Wisp's own fine print says the drop formula has only been tested on lab tissue, not in people. Brand Wegovy and Zepbound are available for a $99 monthly consult, with the pen bought at your pharmacy, where insurance can help. Drops reach 27 states and DC, and a medical director is named.

  • $15.25 less per month on average than The Edit
  • offers FDA-approved brand pens, not just compounded
  • has an oral option if you would rather not inject

Breeze Meds

Metabolic-Fit 78/100 · Grade C

Semaglutide: $199/mo; tirzepatide: Starting at $399/mo. Oral semaglutide starts at $299 and oral tirzepatide at $399; confirm your dose, plan length and cancellation terms.

  • $60 less per month on average than The Edit
  • has an oral option if you would rather not inject
  • scores 78/100 against The Edit's 62

Bloom MD

Metabolic-Fit 45/100 · Grade C

Semaglutide has conflicting plan and purchase-widget prices; tirzepatide costs $249–$459 per 30 days depending on dose. Semaglutide plan labels and purchase-widget prices conflict; tirzepatide ranges from $249 to $459 per 30 days by dose.

  • $10 less per month on average than The Edit
  • offers FDA-approved brand pens, not just compounded
  • has an oral option if you would rather not inject

Pallas Health

Metabolic-Fit 65/100 · Grade C

Pallas charges $199 every four weeks for compounded semaglutide and $299 for tirzepatide, after first-month offers of $139 and $179. Lower annual-plan averages require a longer commitment; provider care and shipping are included.

  • $43.42 less per month on average than The Edit
  • offers FDA-approved brand pens, not just compounded
  • scores 65/100 against The Edit's 62

Midi Health

Metabolic-Fit 72/100 · Grade C

A menopause-focused program that bills insurance for eligible visits. The visit is covered in network or $250 self-pay, and the medication is billed separately from $164 per four-week supply — both figures published. It's built for perimenopause, not the postpartum year.

  • $81.33 less per month on average than The Edit
  • offers FDA-approved brand pens, not just compounded
  • scores 72/100 against The Edit's 62

Medsol RX

Metabolic-Fit 54/100 · Grade C

Three pages of this site quote three different prices for the same treatment: the homepage says semaglutide starts at $169 a month, the packages page shows $169 for month one and $199 from month two, and the semaglutide page says the program "typically ranges from $200-$550 per month" — a ceiling nothing on the site comes near. The packages page is the one to trust, and to its credit every plan total on it recomputes to the exact dollar. It also, on the oral semaglutide cards, tells you that what you will receive is tirzepatide.

  • $60 less per month on average than The Edit
  • offers FDA-approved brand pens, not just compounded
  • has an oral option if you would rather not inject

TOM Weight Loss

Metabolic-Fit 54/100 · Grade C

A small, physician-led practice — Dr. Tran Le personally, capped at ~500 patients — $199/mo semaglutide, $249/mo tirzepatide, all-inclusive, but limited to Texas and Utah only, with no content addressing postpartum or PCOS.

  • $60 less per month on average than The Edit
  • offers FDA-approved brand pens, not just compounded
  • has an oral option if you would rather not inject

Some outbound links earn MomMetabolic a referral fee at no added cost to you, walled off from the Metabolic-Fit Score. Scores are our editorial judgment per the methodology. Not medical advice; see our disclosure.

← All comparisons